HEMOFILIA

Authors

  • Baiq Nindya Annisa Putri Program Studi Pendidikan Dokter, Fakultas Kedokteran Universitas Mataram
  • Devi Rahmadhona Bagian Patologi Klinik, Fakultas Kedokteran Universitas Mataram

DOI:

https://doi.org/10.29303/jk.v11i3.4728

Keywords:

hemofilia, pendarahan, faktor protein koagulasi

Abstract

Hemofilia merupakan penyakit turunan yang ditandai adanya pendarahan berat. Penyakit ini muncul sebagai perdarahan pasca trauma minor atau perdarahan spontan. Hemofilia disebabkan karena kelainan pada faktor protein koagulasi. Faktor VIII (FVIII) menyebabkan hemofilia A, dan faktor IX (FIX) menyebabkan hemofilia B. Hemofilia dapat didiagnosis melalui sekuensing gen dengan cara mengidentifikasi status pembawa. Pada saat prenatal, hemofila dapat dideteksi pada saat janin usia 12 minggu, tetapi memiliki resiko keguguran 0,5-1,0 %. Hemofilia diobati dengan dua pendekatan yakni pengelolaan pendarahan akut dan profilaksis. Pengobatan hemofilia harus memperhatikan dosis, jadwal, dan level target. Pengobatan hemofilia dapat mengunakan faktor VIII rekombinan dengan melibatkan inaktivasi virus dan teknologi skrining yang dinilai lebih aman. Komplikasi dapat terjadi karena kehadiran inhibitor penekan fungsi kerja faktor protein koagulasi, artropati hemofilik, dan pseudotumor pemicu pendarahan jaringan lunak yang berpotensi cedera organ dalam. Upaya pencegahan dilakukan dengan cara menjauhkan penderita dari aktivitas pemicu luka pendarahan fisik, serta memastikan penderita memiliki sistem kekebalan normal

Downloads

Published

2022-09-30

Issue

Vol. 11 No. 3 (2022): Jurnal Kedokteran

Section

Articles

License

Authors who publish with Unram Medical Journal, agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC-BY License). This license allows authors to use all articles, data sets, graphics, and appendices in data mining applications, search engines, websites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in University of Mataram's Journal of Medicine. 
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
  4. This journal is open access journal which means that all content is freely available without charge to users or / institution. Users are allowed to read, download, copy, distribute, print, search, or link to full text articles in this journal without asking prior permission from the publisher or author.